Brief description
CDMO Group, based in Greece, dedicated to the development of pharmaceutical dossiers and the manufacture of generic medicines
Activity
Pharmacist / Healthcare
Tipo de operación
Buy-out
Minority Participation
Investment date
October 2024
Divestment date
__
PharOS, founded in 2002 and based in Athens, is a group focused on the development and contract manufacturing of finished pharmaceutical products, specializing in oral generics.
With 50 products launched and a presence in 115 countries, it generates 80% of its sales in Western Europe.
With 50 products launched and a presence in 115 countries, it generates 80% of its sales in Western Europe.
Its portfolio includes 44 molecules in niche areas (i.e., oncology, cardiovascular or nervous system) and in products and formats with high added value, and has leading clients in the generic drug sector globally.
